Literature DB >> 20050333

The function of CCR3 on mouse bone marrow-derived mast cells in vitro.

Sarah J Collington1, John Westwick, Timothy J Williams, Charlotte L Weller.   

Abstract

The mechanisms governing the population of tissues by mast cells are not fully understood, but several studies using human mast cells have suggested that expression of the chemokine receptor CCR3 and migration to its ligands may be important. In CCR3-deficient mice, a change in mast cell tissue distribution in the airways following allergen challenge was reported compared with wild-type mice. In addition, there is evidence that CCR3 is important in mast cell maturation in mouse. In this study, bone marrow-derived mast cells (BMMCs) were cultured and CCR3 expression and the migratory response to CCR3 ligands were characterized. In addition, BMMCs were cultured from wild-type and CCR3-deficient mice and their phenotype and migratory responses were compared. CCR3 messenger RNA was detectable in BMMCs, but this was not significantly increased after activation by immunoglobulin E (IgE). CCR3 protein was not detected on BMMCs during maturation and expression could not be enhanced after IgE activation. Resting and IgE-activated immature and mature BMMCs did not migrate in response to the CCR3 ligands eotaxin- 1 and eotaxin-2. Comparing wild-type and CCR3-deficient BMMCs, there were no differences in mast cell phenotype or ability to migrate to the mast cell chemoattractants leukotriene B4 and stem cell factor. The results of this study show that CCR3 may not mediate mast cell migration in mouse BMMCs in vitro. These observations need to be considered in relation to the findings of CCR3 deficiency on mast cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20050333      PMCID: PMC2807492          DOI: 10.1111/j.1365-2567.2009.03151.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  37 in total

1.  Expression of the chemokine receptor CCR3 on human mast cells.

Authors:  A de Paulis; F Annunziato; L Di Gioia; S Romagnani; M Carfora; C Beltrame; G Marone; P Romagnani
Journal:  Int Arch Allergy Immunol       Date:  2001 Jan-Mar       Impact factor: 2.749

2.  Mast-cell infiltration of airway smooth muscle in asthma.

Authors:  Christopher E Brightling; Peter Bradding; Fiona A Symon; Stephen T Holgate; Andrew J Wardlaw; Ian D Pavord
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

3.  Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4.

Authors:  Y Li; L Li; R Wadley; S W Reddel; J C Qi; C Archis; A Collins; E Clark; M Cooley; S Kouts; H M Naif; M Alali; A Cunningham; G W Wong; R L Stevens; S A Krilis
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

4.  CCR3 is required for tissue eosinophilia and larval cytotoxicity after infection with Trichinella spiralis.

Authors:  Michael F Gurish; Alison Humbles; Hong Tao; Stella Finkelstein; Joshua A Boyce; Craig Gerard; Daniel S Friend; K Frank Austen
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

5.  CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation.

Authors:  Weilie Ma; Paul J Bryce; Alison A Humbles; Dhafer Laouini; Ali Yalcindag; Harri Alenius; Daniel S Friend; Hans C Oettgen; Craig Gerard; Raif S Geha
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

6.  The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness.

Authors:  Alison A Humbles; Bao Lu; Daniel S Friend; Shoji Okinaga; Jose Lora; Amal Al-Garawi; Thomas R Martin; Norma P Gerard; Craig Gerard
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

7.  Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade.

Authors:  Dai Miyazaki; Takao Nakamura; Masaharu Ohbayashi; Chuan Hui Kuo; Naoki Komatsu; Keiko Yakura; Takeshi Tominaga; Yoshitsugu Inoue; Hidemitsu Higashi; Meguru Murata; Shuzo Takeda; Atsuki Fukushima; Fu-Tong Liu; Marc E Rothenberg; Santa Jeremy Ono
Journal:  Int Immunol       Date:  2009-01-15       Impact factor: 4.823

8.  Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma.

Authors:  N G Carroll; S Mutavdzic; A L James
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

9.  Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences.

Authors:  Reid K Ikeda; Marina Miller; Jyothi Nayar; Linda Walker; Jae Youn Cho; Kirsti McElwain; Shauna McElwain; Eyal Raz; David H Broide
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

10.  CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interleukin 13.

Authors:  Kursteen S Price; Daniel S Friend; Elizabeth A Mellor; Nidia De Jesus; Gerald F M Watts; Joshua A Boyce
Journal:  Am J Respir Cell Mol Biol       Date:  2003-04       Impact factor: 6.914

View more
  5 in total

1.  Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart.

Authors:  Nicola L Diny; Xuezhou Hou; Jobert G Barin; Guobao Chen; Monica V Talor; Julie Schaub; Stuart D Russell; Karin Klingel; Noel R Rose; Daniela Čiháková
Journal:  Eur J Immunol       Date:  2016-10-25       Impact factor: 5.532

2.  Mast cell chemotaxis - chemoattractants and signaling pathways.

Authors:  Ivana Halova; Lubica Draberova; Petr Draber
Journal:  Front Immunol       Date:  2012-05-25       Impact factor: 7.561

3.  Prophylactic Chronic Zinc Administration Increases Neuroinflammation in a Hypoxia-Ischemia Model.

Authors:  Constantino Tomas-Sanchez; Victor Manuel Blanco-Alvarez; Juan Antonio Gonzalez-Barrios; Daniel Martinez-Fong; Guadalupe Garcia-Robles; Guadalupe Soto-Rodriguez; Eduardo Brambila; Maricela Torres-Soto; Alejandro Gonzalez-Vazquez; Ana Karina Aguilar-Peralta; José-Luis Garate-Morales; Luis-Angel Aguilar-Carrasco; Daniel I Limón; Jorge Cebada; Bertha Alicia Leon-Chavez
Journal:  J Immunol Res       Date:  2016-08-18       Impact factor: 4.818

4.  CCR3 Monoclonal Antibody Inhibits Eosinophilic Inflammation and Mucosal Injury in a Mouse Model of Eosinophilic Gastroenteritis.

Authors:  Dae Jin Song; Mun Hee Shim; Nahyun Lee; Young Yoo; Ji Tae Choung
Journal:  Allergy Asthma Immunol Res       Date:  2017-07       Impact factor: 5.764

5.  Proposed criteria to differentiate heterogeneous eosinophilic gastrointestinal disorders of the esophagus, including eosinophilic esophageal myositis.

Authors:  Hiroki Sato; Nao Nakajima; Kazuya Takahashi; Go Hasegawa; Ken-Ichi Mizuno; Satoru Hashimoto; Satoshi Ikarashi; Kazunao Hayashi; Yutaka Honda; Junji Yokoyama; Yuichi Sato; Shuji Terai
Journal:  World J Gastroenterol       Date:  2017-04-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.